PTP||Why should SGLT2i be used for all DKD patients?

backArrow Back
organProtectonlogo

KIDNEY

Why should SGLT2i be used for all DKD patients?

video previous buttonPrevious video play buttonPlay video next buttonNext

EXPERTS GROUP

Prof. Sarah Jarvis

Member of British Empire, General Practitioner Visiting Professor of General Practice, University of Huddersfield

KIDNEY
How can we explain simply the MOA of SGLT2i on Kidney Protection?
784 days
KIDNEY
The role of primary care in reducing kidney disease progression in type 2 diabetes
744 days
PC-SSK-101710